Ranbaxy S.S. - search results

New Zealand - English - Medsafe (Medicines Safety Authority)

ranbaxy-cefaclor

douglas pharmaceuticals limited - cefaclor monohydrate 27.8 mg/ml equivalent to cefaclor 25 mg/ml; - granules for oral suspension - 125 mg/5ml - active: cefaclor monohydrate 27.8 mg/ml equivalent to cefaclor 25 mg/ml excipient: allura red ac citric acid colloidal silicon dioxide simeticone sodium benzoate sodium citrate dihydrate strawberry flavour 052311 ap0551 sucrose xanthan gum - cefaclor is indicated in the treatment of the following infections when caused by susceptible strains of the designated micro-organisms: lower respiratory infections, including pneumonia caused by s. pneumoniae, h. influenzae (including both ampicillin-sensitive and ampicillin-resistant strains), and s. pyogenes (group a beta- haemolytic streptococci), m.catarrhalis, acute bronchitis, and acute exacerbations of chronic bronchitis. upper respiratory infections, including pharyngitis and tonsillitis caused by s. pyogenes (group a beta-haemolytic streptococci) and m. catarrhalis. otitis media caused by s. pneumoniae, h. influenzae (including both ampicillin-sensitive and ampicillin-resistant strains) staphylococci, and s. pyogenes (group a beta-haemolytic streptococci), and m. catarrhalis. skin and soft-tissue infections caused by staphylococcus aureus (including ?-lactamase producing strains), s. pyogenes (group a beta-haemolytic streptococci) and staphylococcus epidermidis (including ?-lactamase produc

New Zealand - English - Medsafe (Medicines Safety Authority)

ranbaxy-cefaclor

douglas pharmaceuticals limited - cefaclor monohydrate 55.6 mg/ml equivalent to cefaclor 50 mg/ml - granules for oral suspension - 250 mg/5ml - active: cefaclor monohydrate 55.6 mg/ml equivalent to cefaclor 50 mg/ml excipient: allura red ac citric acid colloidal silicon dioxide simeticone sodium benzoate sodium citrate dihydrate strawberry flavour 052311 ap0551 sucrose xanthan gum

New Zealand - English - Medsafe (Medicines Safety Authority)

ranbaxy-cefaclor sr

douglas pharmaceuticals limited - cefaclor monohydrate 405.27mg equivalent to cefaclor 375 mg - modified release tablet - 375 mg - active: cefaclor monohydrate 405.27mg equivalent to cefaclor 375 mg excipient: colloidal silicon dioxide hyprolose hypromellose lactose monohydrate magnesium stearate opacode opadry blue purified talc